NCT07049705

Brief Summary

The study titled "Factors Influencing Bradycardia During Spinal Anaesthesia in Obstetric Patients Undergoing Caesarean Section"" aims to investigate the causes and patterns of bradycardia in pregnant women receiving spinal anesthesia during cesarean deliveries. Bradycardia, defined as a heart rate below 60 beats per minute, is a known complication of spinal anesthesia, often resulting from sympathetic blockade and unopposed parasympathetic activity. This condition may lead to hypotension, decreased cardiac output, and compromised fetal oxygenation.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
289

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 17, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 25, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 3, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2026

Completed
Last Updated

July 3, 2025

Status Verified

June 1, 2025

Enrollment Period

6 months

First QC Date

June 25, 2025

Last Update Submit

June 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • structured questionnaire

    1. Section A: Demographic and Baseline Information Age, weight, height, gestational age, parity, medical history, medications. 2. Section B: Anesthetic and Surgical Details Indication for cesarean (elective/emergency), baseline heart rate and BP, type/dose of anesthetic, sensory block level, fluid administration, blood loss. 3. Section C: Intraoperative Hemodynamic Events Occurrence of bradycardia (HR \< 60 bpm), lowest HR, time to bradycardia, associated hypotension, interventions used, maternal symptoms. 4. Section D: Neonatal Outcomes Apgar scores at 1 and 5 minutes, NICU admission and reasons. Scoring: There is no numerical scoring system described. Instead: Responses are mostly categorical or numerical entries (e.g., Yes/No, HR value, BP value, Apgar score).

    12 Months

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The research seeks to enhance the understanding of both patient-specific and procedural risk factors, contributing to improved clinical management, safer anesthesia practices, and better maternal-fetal outcomes. Ethical approval and informed consent protocols are included to ensure participant safety and data confidentiality.

You may qualify if:

  • Obstetric patients aged 18-40 years.
  • Undergoing elective or emergency cesarean sections under spinal anesthesia.
  • Classified as ASA Physical Status I or II (relatively healthy or with mild systemic disease).
  • Provided informed consent (either by the patient or legal guardian).

You may not qualify if:

  • Patients with pre-existing cardiac conditions (e.g., arrhythmias, conduction abnormalities).
  • Patients taking medications that affect heart rate, such as beta-blockers or calcium channel blockers.
  • Patients with contraindications to spinal anesthesia (e.g., coagulopathy, infection at the injection site).
  • Those undergoing combined spinal-epidural or general anesthesia.
  • Patients with incomplete medical records or unable to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maqsood Medical complex

Peshawar, Khyber Pakhtunkhwa, Pakistan

Location

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 25, 2025

First Posted

July 3, 2025

Study Start

March 17, 2025

Primary Completion

September 1, 2025

Study Completion

February 28, 2026

Last Updated

July 3, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations